Cancer Alternative Therapy Clinical Trials
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003517 - Recruiting
adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00005838 - Completed
Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Combination Chemotherapy, Monoclonal Antibody Therapy, and Surgery in Treating Women With Stage II, Stage III, or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00006110 - Active, not recruiting
stage II breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
- Docetaxel With or Without Bevacizumab Followed by Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00027885 - Active, not recruiting
stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
- Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
- Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
ClinicalTrials.gov Identifier: NCT00003492 - Recruiting
recurrent non-small cell lung cancer; large cell lung cancer; stage IV non-small cell lung cancer
- Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003531 - Recruiting
recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Soy Isoflavone Compared With No Treatment Before Surgery in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00022269 - No longer recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIC breast cancer
- Gene Therapy in Treating Patients With Cancer
ClinicalTrials.gov Identifier: NCT00004178 - Active, not recruiting
Lung Cancer; Pancreatic Cancer; Gastric Cancer; Salivary Gland Cancer; Renal Cell Cancer; Endometrial Cancer; Esophageal Cancer; Head and Neck Cancer; ...
- Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003851 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; Nutrition; adenocarcinoma of the pancreas
- Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00030342 - Recruiting
stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; Stage IV Renal Cell Cancer; ...
- Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00003487 - Recruiting
stage IV esophageal cancer; recurrent esophageal cancer; Adenocarcinoma of the Esophagus
- Antineoplaston Therapy in Treating Patients With Colon Cancer
ClinicalTrials.gov Identifier: NCT00003486 - Recruiting
stage IV colon cancer; recurrent colon cancer; adenocarcinoma of the colon
- Antineoplaston Therapy in Treating Women With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00003455 - Recruiting
stage IV breast cancer; recurrent breast cancer
- Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer
ClinicalTrials.gov Identifier: NCT00003536 - Recruiting
stage IV breast cancer; recurrent breast cancer
- Antineoplaston Therapy in Treating Patients With Stage IV Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003452 - Recruiting
Recurrent Bladder Cancer; Stage IV Bladder Cancer
- Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
ClinicalTrials.gov Identifier: NCT00026117 - Completed
stage IV colon cancer; stage IV breast cancer; recurrent breast cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; ...
- Genistein in Treating Patients Who Are Undergoing Surgery for Bladder Cancer
ClinicalTrials.gov Identifier: NCT00118040 - Suspended
stage 0 bladder cancer; recurrent bladder cancer; stage I bladder cancer; stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer
- Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00134069 - Active, not recruiting
recurrent colon cancer; stage III colon cancer; stage IV colon cancer; recurrent rectal cancer; stage III rectal cancer; Stage IV rectal cancer
- Tandem Autologous Stem Cell Transplantation With or Without Maintenance Therapy After the Second Transplantation Compared With Autologous Stem Cell Transplantation Followed By Matched Sibling Allogeneic Stem Cell Transplantation in Patients With Stage II
ClinicalTrials.gov Identifier: NCT00075829 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00070057 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00055705 - Completed
Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; thorax and respiratory cancer; unclassified and other cancer
- Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00093652 - Active, not recruiting
Adenocarcinoma of the Esophagus; recurrent esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer; ...
- Bevacizumab and Combination Chemotherapy in Treating Patients Who Have Undergone Surgery for Breast Cancer That Has Spread to the Lymph Nodes
ClinicalTrials.gov Identifier: NCT00119262 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; Male Breast Cancer
- Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00003489 - Active, not recruiting
Head and Neck Cancer
- Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
ClinicalTrials.gov Identifier: NCT00004234 - Active, not recruiting
Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ...
- Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00041080 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; Fallopian Tube Cancer; ...
- Biological Therapy in Treating Patients With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00004604 - Active, not recruiting
Lung Cancer; Testicular Cancer; ovarian epithelial cancer; Pancreatic Cancer; Colon Cancer; Thyroid Cancer; Gastric Cancer; Salivary Gland Cancer; ...
- Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors
ClinicalTrials.gov Identifier: NCT00028535 - Active, not recruiting
recurrent breast cancer; recurrent gastric cancer; recurrent non-small cell lung cancer; recurrent ovarian epithelial cancer; ...
- Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment
ClinicalTrials.gov Identifier: NCT00016237 - Completed
extensive stage small cell lung cancer; stage IV non-small cell lung cancer; Stage IV Renal Cell Cancer; Squamous Cell Lung Cancer; ...
- IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer
ClinicalTrials.gov Identifier: NCT00100893 - Recruiting
Breast Cancer
- Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated
ClinicalTrials.gov Identifier: NCT00025337 - Active, not recruiting
stage III colon cancer; stage IV colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; ...
- Isotretinoin, Interferon alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00054561 - Active, not recruiting
Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
- Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00101062 - Active, not recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
- Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00091273 - Active, not recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- Combination Chemotherapy and Peripheral Stem Cell Transplantation Followed by Interleukin-2 and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00003199 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; inflammatory breast cancer
- Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00126542 - Active, not recruiting
recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
- Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00091026 - Recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
- Lymphocyte Therapy in Treating Patients With Kidney Cancer
ClinicalTrials.gov Identifier: NCT00002589 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00009750 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
ClinicalTrials.gov Identifier: NCT00003530 - Active, not recruiting
stage IV childhood liver cancer; recurrent childhood liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer
- Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva
ClinicalTrials.gov Identifier: NCT00003525 - Active, not recruiting
stage IV cervical cancer; recurrent cervical cancer; stage IV vulvar cancer; recurrent vulvar cancer
- Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00003514 - Recruiting
Merkel Cell Carcinoma; Islet Cell Carcinoma; Neuroendocrine Carcinoma; Pituitary Tumor
- Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer
ClinicalTrials.gov Identifier: NCT00021333 - Active, not recruiting
Lung Cancer; Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Thyroid Cancer; Oropharyngeal Cancer
- Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00089297 - Active, not recruiting
Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
- Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
ClinicalTrials.gov Identifier: NCT00003170 - Active, not recruiting
Pancreatic Cancer; Vulvar Cancer; Renal Cell Cancer; Endometrial Cancer; Testicular Cancer; ovarian epithelial cancer; Colon Cancer; Rectal Cancer; ...
- Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00003313 - Active, not recruiting
oral complications of cancer and cancer therapy; stage IIIA non-small cell lung cancer; stage II non-small cell lung cancer; Drug Toxicity; ...
- Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004124 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
- Bevacizumab Combined With Either Docetaxel or Erlotinib Compared With Docetaxel Alone in Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00098410 - Recruiting
recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; ...
- Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, or Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00101348 - Recruiting
Gastrointestinal Cancer; Head and Neck Cancer; kidney and urinary cancer; thorax and respiratory cancer
- Bevacizumab and Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00128674 - Recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00099086 - Recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Palifermin in Reducing or Preventing Mucositis in Patients Who Are Receiving Radiation Therapy and Chemotherapy Followed by an Autologous Stem Cell Transplant for Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00126529 - Recruiting
Drug Toxicity; Leukemia; Lymphoma; oral complications of cancer and cancer therapy; plasma cell neoplasm; radiation toxicity
- Antineoplaston Therapy in Treating Patients With Brain Stem Glioma
ClinicalTrials.gov Identifier: NCT00003459 - Active, not recruiting
recurrent adult brain tumor; adult brain stem glioma; untreated childhood brain stem glioma; recurrent childhood brain stem glioma
- Antineoplaston Therapy in Treating Patients With Ependymoma
ClinicalTrials.gov Identifier: NCT00003479 - Active, not recruiting
adult ependymoma; newly diagnosed childhood ependymoma; recurrent childhood ependymoma; adult anaplastic ependymoma
- Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00003456 - Active, not recruiting
adult glioblastoma
- Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
ClinicalTrials.gov Identifier: NCT00003526 - Recruiting
adenocarcinoma of unknown primary; recurrent carcinoma of unknown primary
- Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
ClinicalTrials.gov Identifier: NCT00003453 - Recruiting
stage IV adrenocortical carcinoma; recurrent adrenocortical carcinoma
- Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
ClinicalTrials.gov Identifier: NCT00088946 - Active, not recruiting
transitional cell carcinoma of the bladder; stage 0 bladder cancer; stage I bladder cancer
- Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00080873 - Active, not recruiting
Cancer; oral complications of cancer and cancer therapy
- Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
ClinicalTrials.gov Identifier: NCT00004024 - Active, not recruiting
adult brain tumor
- Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00006113 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Combination Chemotherapy Followed by Radiation Therapy With or Without Surgery in Treating Women With Locally Advanced or Inflammatory Breast Cancer
ClinicalTrials.gov Identifier: NCT00017095 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer
- Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00002475 - Active, not recruiting
Breast Cancer; Colorectal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer; pleura cancer
- Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy
ClinicalTrials.gov Identifier: NCT00004115 - Active, not recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00022230 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003734 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Pemetrexed Disodium, Carboplatin, and Radiation Therapy with Or Without Cetuximab in Treating Patients with Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00117962 - Recruiting
stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; ...
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Erlotinib and Bevacizumab in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00054132 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00009763 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00023959 - Active, not recruiting
Head and Neck Cancer
- Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00067015 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; Quality of Life
- Cetuximab, Combination Chemotherapy, and Radiation therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00109850 - Active, not recruiting
Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage III esophageal cancer
- Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
ClinicalTrials.gov Identifier: NCT00003494 - Active, not recruiting
recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; Bronchoalveolar Cell Lung Cancer
- Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
ClinicalTrials.gov Identifier: NCT00003495 - Active, not recruiting
recurrent non-small cell lung cancer; Squamous Cell Lung Cancer; stage IV non-small cell lung cancer
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003532 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; stage III ovarian germ cell tumor; ...
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003516 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003520 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; Renal Cell Adenocarcinoma; ...
- Antineoplaston Therapy in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00003524 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
- Antineoplaston Therapy in Treating Children With Brain Tumors
ClinicalTrials.gov Identifier: NCT00003458 - Recruiting
childhood brain tumor
- Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma
ClinicalTrials.gov Identifier: NCT00003468 - Recruiting
low-grade childhood cerebral astrocytoma; recurrent childhood cerebral astrocytoma
- Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
ClinicalTrials.gov Identifier: NCT00003476 - Recruiting
childhood brain tumor; childhood meningioma
- Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors
ClinicalTrials.gov Identifier: NCT00003460 - Recruiting
untreated childhood supratentorial primitive neuroectodermal tumors; recurrent childhood supratentorial primitive neuroectodermal tumors
- Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
ClinicalTrials.gov Identifier: NCT00003535 - Recruiting
high-grade childhood cerebral astrocytoma; recurrent childhood cerebral astrocytoma
- Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System
ClinicalTrials.gov Identifier: NCT00003469 - Recruiting
childhood rhabdoid tumor of the central nervous system
- Antineoplaston Therapy in Treating Children With Visual Pathway Glioma
ClinicalTrials.gov Identifier: NCT00003477 - Recruiting
untreated childhood visual pathway glioma; recurrent childhood visual pathway glioma
- Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
ClinicalTrials.gov Identifier: NCT00003508 - Recruiting
advanced malignant mesothelioma; recurrent malignant mesothelioma
- Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma
ClinicalTrials.gov Identifier: NCT00003470 - Recruiting
recurrent adult brain tumor; adult anaplastic astrocytoma
- Antineoplaston Therapy in Treating Patients With Brain Tumors
ClinicalTrials.gov Identifier: NCT00003457 - Recruiting
ACTH-producing pituitary tumor; TSH producing pituitary tumor; adult brain tumor
- Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003499 - Recruiting
grade 1 follicular lymphoma; grade 2 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma
- Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00003502 - Recruiting
contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; stage IV mantle cell lymphoma; ...
- Antineoplaston Therapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003511 - Recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003498 - Recruiting
adult non-Hodgkin's lymphoma
- Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma
ClinicalTrials.gov Identifier: NCT00003505 - Recruiting
primary central nervous system lymphoma
- Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
ClinicalTrials.gov Identifier: NCT00003475 - Recruiting
adult brain tumor
- Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas
ClinicalTrials.gov Identifier: NCT00003473 - Recruiting
recurrent adult brain tumor; Mixed Gliomas
